Quantitative electroencephalography (EEG) was performed on eight of ten Alzheimer patients in a double-blind, inpatient-outpatient tetrahydroaminoacridine (THA) and lecithin trial. Neuropsychological measures were related to EEG activity. Patient baseline dominant parietal rhythms (DPRs) and power spectral distributions differed significantly from controls. Severity of cognitive impairment was related to the degree of parietal slowing. Inpatient THA treatment resulted in increased DPR frequency in six of eight patients. Four of eight inpatients demonstrated reduced power in the delta and theta bands. During the outpatient long-term treatment phase, six of the patients were able to continue. Three of these improved significantly on tests of cognition. Two of these improved patients demonstrated DPRs with increased fre quency. One of these patients also showed a decrease in slow-wave activity. Thus, THA may accelerate DPRs while re ducing power in the slower EEG bands. However, there appears to be only a tentative coupling between individual quantitative EEG measures and cognitive performance associated with THA administration (J Geriatr Psychiatry Neurol 1991;4:127-133).
Get full access to this article
View all access options for this article.
References
1.
Evans DA, Funkenstein HH, Albert MS: Prevalence of Alzheimer's disease in a community population of older persons . JAMA1989;262:2551-2556.
2.
Pedley TA, Miller JA: Clinical neurophysiology of aging and dementia, in Mayeux R, Rosen WG (eds): Advances in Neurology, Vol 38: The Dementias. New York , Raven Press, 1984, pp 31-50.
3.
Brenner RP, Ulrich RF, Spiker DG, et al: Computerized EEG spectral analysis in elderly normal, demented and depressed subjects. Electroencephalogr Clin Neurophysiol1986;64:483-492.
4.
Coben LA, Danziger W., Storandt M., et al: A longitudinal EEG study of mild senile dementia of Alzheimer type changes at 1 year and at 2.5 years. Electroencephalogr Clin Neurophysiol1985;61:101-112.
5.
Penttila M., Partanen JV, Soininen H., et al: Quantitative analysis of occipital EEG in different stages of Alzheimer's disease. Electroencephalogr Clin Neurophysiol1985;60:1-6.
6.
Kanai T., Szerb JC: Mesencephalic reticular activating system and cortical acetylcholine output . Nature1965;205:80-82.
7.
Sie G., Jasper HH, Wolfe I., et al: Rate of ACh release from cortical surface in encéphale and cerveau isolé preparations in relation to arousal and epileptic activation of the EEG. Electroencephalogr Clin Neurophysiol1965;18:206.
8.
Karczmar AG: Brain acetylcholine and animal electrophysiology, in Davis KL, Berger PA (eds): Acetylcholine and Neuropsychiatric Disease. New York, Plenum Press, 1979, pp 265-310.
9.
Gustafson L. , Edvinsson L., Dahlgren N., et al: Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG. Psychopharmacol1987;93:31-35.
10.
Coyle JT, Price DT, DeLong MR: Alzheimer's disease: A disorder of cortical cholinergic innervation . Science1983;219: 1184-1190.
11.
Whitehouse PJ, Price DT, Clark AW, et al: Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis . Ann Neurol1981;10:122-126.
12.
Stewart D., Macfabe DF, Vanderwolf CH, et al: Cholinergic activation of the electrocorticogram: Role of the substantia innominata and effects of atropine and quinuclidinyl benzilate . Brain Res1984;322:219-232.
13.
Summers WK, Majovski LH, Marsh GM, et al: Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med1986 ;315:1241-1245.
14.
Fitten LJ, Perryman KM, Gross PL, et al: Treatment of Alzheimer's disease with short and longterm oral THA and leithin: A double-blind study. Am J Psychiatry1990;147:239-242.
15.
McKhann G., Drachman D., Folstein M., et al: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group. Neurology1984;34:939-944.
16.
Folstein MF , Folstein SE, McHugh PR: Mini-mental state: A practical method for grading the cognitive state of patients for the clinician . J Psychiatr Res1975;12:189-198.
17.
Benton Al, Hamsher K deS: Multilingual Aphasia Examination. Iowa City, University of Iowa, 1976 .
18.
Reisberg B. , Ferris SH, deLeon MJ, Crook T.: The global deterioration scale (GDS): An instrument for the assessment of primary degenerative dementia (PDD). Am J Psychiatry1982;139:1139.
19.
Katz S.: Studies of illness in the aged: The index of ADL, a standardized measure of biological and psychological function. JAMA1963;185:914-919.
20.
Lawton MP, Brody E.: Assessment of older people: Self maintaining and instrumental activities of daily living. Gerontologist1969;9:179-186.
21.
Park TH, Tachiki KH, Summers WK, et al: Isolation and the fluorometric, high-performance liquid chromatographic determination of tacrine. Anal Biochem1986 ;159:358-362.
22.
Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatry1984;141:1352-1364.
23.
Schwartz GE : Development and validation of the Geriatric Evaluation by Relatives Rating Instrument (GERRI). Psychol Rep1983;53:479-488.
Brun A., Gustafson L.: Distribution of cerebral degeneration in Alzheimer's disease. A clinical-pathological study. Arch Psychiatr Nevenkr1976 ;223:15-33.
26.
Sheridan PH , Sato S., Foster N., et al: Relation of EEG alpha background to parietal lobe function in Alzheimer's disease as measured by positron emission tomography and psychometry. Neurology1988 ;38:747-750.
27.
Gauthier S. , Bouchard R., Lamontagne A.: Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease . N Engl J Med1990; 322:1272-1276.
28.
Mirsky AF: Behavioral and psychophysiological markers of disordered attention . Environ Health Perspect1987;74:191-199.
29.
Posner MI, Petersen SE, Fox PT, et al: Localization of cognitive operations in the human brain. Science1988;240:1627-1632.
30.
Grady CL, Haxby JV, Horwitz B., et al: Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol1988;10:576-596.
